Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SBBP - Strongbridge Biopharma's Recorlev successful in Cushing's syndrome study


SBBP - Strongbridge Biopharma's Recorlev successful in Cushing's syndrome study

  • Strongbridge Biopharma (NASDAQ:SBBP) announces positive results from a 44-subject Phase 3 clinical trial, LOGICS, evaluating Recorlev (levoketoconazole) in patients with endogenous Cushing's syndrome, a metabolic disorder characterized by the excess production of the hormone cortisol.
  • More news on: Strongbridge Biopharma plc, Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Strongbridge Biopharma plc
Stock Symbol: SBBP
Market: NASDAQ
Website: strongbridgebio.com

Menu

SBBP SBBP Quote SBBP Short SBBP News SBBP Articles SBBP Message Board
Get SBBP Alerts

News, Short Squeeze, Breakout and More Instantly...